1.84BMarket Cap2.76P/E (TTM)
32.520High31.330Low839.70KVolume31.930Open31.990Pre Close26.82MTurnover1.66%Turnover Ratio2.76P/E (Static)57.30MShares62.58052wk High1.19P/B1.63BFloat Cap27.14052wk Low--Dividend TTM50.72MShs Float138.850Historical High--Div YieldTTM3.72%Amplitude15.770Historical Low31.935Avg Price1Lot Size
Agios Pharmaceuticals Stock Forum
Clinical Trial Breakthrough: Agios' Blood Disorder Drug Outperforms Placebo in Rare Pediatric Disease
Agios Delivers Record PYRUKYND Growth as FDA Decision Looms: Q4 Earnings Deep Dive
$Humacyte (HUMA.US)$ : 🤔
⇨ Human Acellular Vessel (HAV)™
‣ Vascular Trauma
‣ PDUFA: 8/10/24 (BLA)
🗓️ Last Week’s AdCom & PDUFAs:
$Zevra Therapeutics (ZVRA.US)$ : Favorable AdCom 👍
🗳️ 11-5 votes in favor
⇨ Arimoclomol
‣ Niemann-Pick disease type C
‣ AdCom: 8/2/24 (NDA)
$Adaptimmune Therapeutics (ADAP.US)$ : Approved 🎉
⇨ TECELRA (afamitresgene autoleucel)
‣ Synovial sarcoma
‣ PDUFA: 8/4/24 (BLA)
$GlaxoSmithKline (GSK.US)$ : Approved 🎉
⇨ Jemperli
‣ Endometria...
HOW MANY STUPID TRADERS HERE, LOSING AND STILL TRADING 🤔🤔🤔
Bad Demon Trap = Xi Zor Gai 😏
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 3
$Liquidia (LQDA.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$MorphoSys (MOR.US)$ Phase 3
$Immunocore (IMCR.US)$ Phase 3
$Crinetics (CRNX.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$Capricor Therapeutics (CAPR.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3 ...
No comment yet